Evercore ISI raised the firm’s price target on Versigent (VGNT) to $60 from $55 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VGNT:
- HubSpot downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
- Versigent initiated with an Overweight at Morgan Stanley
- Versigent price target raised to $38 from $35 at Deutsche Bank
- Versigent price target raised to $49 from $47 at TD Cowen
- Versigent price target raised to $49 from $43 at UBS